Literature DB >> 1346772

Haplotype analysis at the low density lipoprotein receptor locus: application to the study of familial hypercholesterolemia in Israel.

N Berkman1, B S Weir, S Pressman-Schwartz, A Reshef, E Leitersdorf.   

Abstract

Familial hypercholesterolemia (FH) results from mutations in the low density lipoprotein (LDL) receptor gene. It has been shown that restriction fragment length polymorphisms (RFLPs) associated with this gene may be used for family and population studies. The present investigation is a population-based study of 19 Jewish families with hypercholesterolemia representing 9 different countries of origin. Ten RFLP sites were used to construct 24 different haplotypes from 112 chromosomes. These haplotypes vary in frequency from 0.9% to 28.6%. Five previously undescribed haplotypes, which comprise 8.1% of the sample, are reported here. The six most common haplotypes account for 70% of the sample. Segregation analysis reveals that, in Israel, distinct LDL receptor haplotypes are associated with hypercholesterolemia in 12 (63%) out of the 19 Jewish families. Five LDL receptor haplotypes co-segregate with hypercholesterolemia. Two of these haplotypes seem to be unique to specific population groups in Israel and may therefore represent founder mutations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346772     DOI: 10.1007/bf00215674

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  High-resolution analysis of a hypervariable region in the human apolipoprotein B gene.

Authors:  E H Ludwig; W Friedl; B J McCarthy
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

2.  The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolaemia.

Authors:  M J Kotze; E Langenhoven; L Warnich; L du Plessis; M P Marx; C J Oosthuizen; A E Retief
Journal:  S Afr Med J       Date:  1989-10-21

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum.

Authors:  M A Lehrman; W J Schneider; M S Brown; C G Davis; A Elhammer; D W Russell; J L Goldstein
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

5.  Homozygous familial hypercholesterolemia among French Canadians in Québec Province.

Authors:  S Moorjani; M Roy; C Gagné; J Davignon; D Brun; M Toussaint; M Lambert; L Campeau; S Blaichman; P Lupien
Journal:  Arteriosclerosis       Date:  1989 Mar-Apr

Review 6.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  A host of hypercholesterolaemic homozygotes in South Africa.

Authors:  H C Seftel; S G Baker; M P Sandler; M B Forman; B I Joffe; D Mendelsohn; T Jenkins; C J Mieny
Journal:  Br Med J       Date:  1980-09-06

8.  A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.

Authors:  V Meiner; D Landsberger; N Berkman; A Reshef; P Segal; H C Seftel; D R van der Westhuyzen; M S Jeenah; G A Coetzee; E Leitersdorf
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

9.  Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.

Authors:  H H Hobbs; E Leitersdorf; C C Leffert; D R Cryer; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  Linkage disequilibrium between DNA markers at the low-density lipoprotein receptor gene.

Authors:  R A Hegele; R Plaetke; J M Lalouel
Journal:  Genet Epidemiol       Date:  1990       Impact factor: 2.135

View more
  6 in total

1.  Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease.

Authors:  L A Salazar; M H Hirata; S D Giannini; N Forti; J Diament; J S Issa; R D Hirata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia.

Authors:  L A Salazar; M H Hirata; E C Quintão; R D Hirata
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  A missense mutation in the low density lipoprotein receptor gene causes familial hypercholesterolemia in Sephardic Jews.

Authors:  E Leitersdorf; A Reshef; V Meiner; E J Dann; Y Beigel; F G van Roggen; D R van der Westhuyzen; G A Coetzee
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

4.  Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia.

Authors:  E Leitersdorf; S Eisenberg; O Eliav; N Berkman; E J Dann; D Landsberger; E Sehayek; V Meiner; T K Peters; E N Muratti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Gender-related response to fluvastatin in patients with heterozygous familial hypercholesterolaemia.

Authors:  E Leitersdorf
Journal:  Drugs       Date:  1994       Impact factor: 9.546

6.  Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia.

Authors:  T P Leren; H Sundvold; O K Rødningen; S Tonstad; K Solberg; L Ose; K Berg
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.